Initial experience in implementing quantitative DCE-MRI to predict breast cancer therapy response in a multi-center and multi-vendor platform setting.
Moloney B, Li X, Hirano M, Saad Eddin A, Lim JY, Biswas D, Kazerouni AS, Tudorica A, Li I, Bryant ML, Wille C, Pyle C, Rahbar H, Hsieh SK, Rice-Stitt TL, Dintzis SM, Bashir A, Hobbs E, Zimmer A, Specht JM, Phadke S, Fleege N, Holmes JH, Partridge SC, Huang W.
Moloney B, et al. Among authors: wille c.
Front Oncol. 2024 Nov 29;14:1395502. doi: 10.3389/fonc.2024.1395502. eCollection 2024.
Front Oncol. 2024.
PMID: 39678499
Free PMC article.